Free Trial

Atria Investments Inc Cuts Stock Holdings in Ambev S.A. (NYSE:ABEV)

Ambev logo with Consumer Staples background
Remove Ads

Atria Investments Inc lessened its holdings in Ambev S.A. (NYSE:ABEV - Free Report) by 71.3% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 61,637 shares of the company's stock after selling 152,928 shares during the period. Atria Investments Inc's holdings in Ambev were worth $114,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. CORDA Investment Management LLC. purchased a new position in Ambev in the fourth quarter valued at approximately $11,987,000. Allspring Global Investments Holdings LLC lifted its stake in Ambev by 39.9% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 18,519,980 shares of the company's stock valued at $33,892,000 after purchasing an additional 5,283,746 shares during the last quarter. Itau Unibanco Holding S.A. purchased a new position in Ambev in the third quarter valued at approximately $3,259,000. Jane Street Group LLC lifted its stake in Ambev by 132.9% in the third quarter. Jane Street Group LLC now owns 1,976,147 shares of the company's stock valued at $4,822,000 after purchasing an additional 1,127,719 shares during the last quarter. Finally, Private Management Group Inc. lifted its stake in Ambev by 8.1% in the fourth quarter. Private Management Group Inc. now owns 14,512,234 shares of the company's stock valued at $26,848,000 after purchasing an additional 1,083,882 shares during the last quarter. Hedge funds and other institutional investors own 8.13% of the company's stock.

Ambev Stock Performance

Shares of NYSE:ABEV traded up $0.01 during trading on Friday, hitting $2.36. 13,848,921 shares of the company were exchanged, compared to its average volume of 25,870,029. The company has a market cap of $37.10 billion, a PE ratio of 13.08, a P/E/G ratio of 5.80 and a beta of 0.94. The stock has a 50 day moving average of $1.98 and a 200 day moving average of $2.12. Ambev S.A. has a 52-week low of $1.76 and a 52-week high of $2.56. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.20 and a quick ratio of 0.89.

Remove Ads

Ambev (NYSE:ABEV - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.01). The firm had revenue of $4.63 billion during the quarter, compared to the consensus estimate of $22.42 billion. Ambev had a return on equity of 16.12% and a net margin of 17.02%. As a group, equities research analysts predict that Ambev S.A. will post 0.18 EPS for the current year.

Ambev Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, April 14th. Investors of record on Tuesday, March 18th will be paid a $0.0221 dividend. The ex-dividend date of this dividend is Tuesday, March 18th. This represents a $0.09 dividend on an annualized basis and a yield of 3.75%. Ambev's dividend payout ratio is presently 52.94%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on ABEV. StockNews.com began coverage on Ambev in a research note on Monday, January 27th. They issued a "buy" rating on the stock. Barclays dropped their price objective on Ambev from $2.50 to $2.00 and set an "equal weight" rating on the stock in a research note on Tuesday, January 21st. Citigroup restated a "neutral" rating on shares of Ambev in a research report on Wednesday, January 22nd. Finally, Bank of America downgraded Ambev from a "buy" rating to a "neutral" rating in a research report on Friday, January 17th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Ambev has a consensus rating of "Hold" and a consensus target price of $2.45.

View Our Latest Stock Report on ABEV

About Ambev

(Free Report)

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.

Featured Stories

Institutional Ownership by Quarter for Ambev (NYSE:ABEV)

Should You Invest $1,000 in Ambev Right Now?

Before you consider Ambev, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.

While Ambev currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads